New drug vs old drug: which one works better?
NCT ID NCT07311811
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two drugs, IN-M00007 and IN-R00007, to see if they are equivalent in healthy adults aged 19 to 59. Sixty volunteers will take a single dose of each drug in random order, and researchers will measure how the drugs are absorbed and how safe they are. The goal is to check if the new drug can be used as a substitute for the existing one.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rosuvastatin and Ezetimibe combination
- What this could lead to
- If successful, this could confirm that the new drug works the same as the existing one, potentially offering a generic alternative.
- What could go wrong
- This is an early phase 1 trial in only 60 healthy people, so results may not apply to patients. The study is not yet recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H PLUS Yangji Hospital, Clinical Trial Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults